{"id":"W4225276302","doi":"10.5826/dpc.1202a104","title":"Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial","year":2022,"lang":"en","type":"article","venue":"Dermatology Practical & Conceptual","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriatic arthritis; Adalimumab; Psoriasis; Dermatology; Plaque psoriasis; Arthritis; Traditional medicine; Internal medicine; Secukinumab; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001778796,0.0002700024,0.0009269694,0.0000692883,0.0003359611,0.00001835176,0.00008185498,0.0001126899,0.00009367113],"category_scores_gemma":[0.00178448,0.0001999854,0.00006164196,0.0002128925,0.0005125924,0.0001401921,0.0002154372,0.0005022699,0.000005343576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008486372,"about_ca_system_score_gemma":0.0001868162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002123998,"about_ca_topic_score_gemma":0.0001433882,"domain_scores_codex":[0.9973744,0.0006182599,0.0006554762,0.0005494258,0.0004341811,0.0003682326],"domain_scores_gemma":[0.9951544,0.004012739,0.0002578546,0.0003035761,0.0001077298,0.0001636818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9694771,0.001228319,0.001139852,0.000005073553,0.0007676422,0.0003483749,0.004313818,0.00001373129,0.000001336952,0.0004775233,0.0003531027,0.02187412],"study_design_scores_gemma":[0.9266112,0.006353761,0.05784365,0.00009029621,0.0005089225,0.0001438637,0.005649377,0.00005058698,0.00004072439,0.00005038394,0.002428689,0.0002285058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904438,0.0007956925,0.00001087879,0.00503504,0.0003667515,0.00250914,0.000487636,0.00002168368,0.0003293887],"genre_scores_gemma":[0.9984599,0.0002318723,0.0003237809,0.0004511154,0.00006020931,0.0002372226,0.0002026693,0.00002302128,0.00001016719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0567038,"threshold_uncertainty_score":0.8155168,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02590724216956507,"score_gpt":0.2801561688591698,"score_spread":0.2542489266896047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}